www.bioaccessla.com
Open in
urlscan Pro
99.83.177.15
Public Scan
Submitted URL: https://bioaccesslabioacces.com/
Effective URL: https://www.bioaccessla.com/
Submission: On October 29 via api from US — Scanned from CA
Effective URL: https://www.bioaccessla.com/
Submission: On October 29 via api from US — Scanned from CA
Form analysis
0 forms found in the DOMText Content
0 The International Business Times has published an article about our work in helping Medtech companies develop their clinical plans in Latin America. Check it out! Skip to Content Home Solutions Services About Resources News Blog Testimonials FAQ Podcast Careers CONTACT US Open Menu Close Menu Home Solutions Services About Resources News Blog Testimonials FAQ Podcast Careers CONTACT US Open Menu Close Menu Home Solutions Services About Folder: Resources Podcast Careers CONTACT US Back News Blog Testimonials FAQ YOUR GATEWAY TO ACCELERATED MEDTECH CLINICAL STUDY RESULTS LATIN AMERICA’S LEADING CONTRACT RESEARCH ORGANIZATION (CRO) PROVIDES WORLD-CLASS CLINICAL RESEARCH SERVICES, RAPIDLY ADVANCING YOUR MEDICAL DEVICE FROM PILOT STUDY TO COMMERCIALIZATION BIOACCESS® BRINGS CERTAINTY We at bioaccess® are experts in delivering cost-effective, high-quality medical device CRO services in Latin America. We collaborate with Medtech startups seeking accelerated clinical study results. With bioaccess® , you quickly and reliably receive regulatory approval, clinical research site activation, subject recruitment, and trial data. We bring you certainty in: ✔️ Moving to the next phase (an FDA IDE pivotal study) ✔️ Raising funds ✔️ A successful acquisition LEARN MORE ADVANCE YOUR MEDICAL DEVICE SOONER Pilot Studies Early-Feasibility Studies (EFS) First-In-Human Studies (FIH) Pivotal Studies Post-Market Clinical Follow-Up (PMCF) Medtech clinical trials require high experience levels, specialized knowledge, and flexibility. Our clinical research team is composed of experts with a proven background of 20+ years in Medtech, focused only on: * Early-Feasibility Studies (EFS) * First-In-Human Studies (FIH) * Pilot Studies * Pivotal Studies * Post-Market Clinical Follow-Up Studies (PMCF) bioaccess® has the expertise and customized approach you need to advance your medical device sooner. VIEW SERVICES TRUSTED BY Slide 1 Slide 1 (current slide) Slide 2 Slide 2 (current slide) Slide 3 Slide 3 (current slide) Slide 4 Slide 4 (current slide) Slide 5 Slide 5 (current slide) Slide 6 Slide 6 (current slide) Slide 7 Slide 7 (current slide) Slide 8 Slide 8 (current slide) Slide 9 Slide 9 (current slide) Testimonials * “I'm very grateful for the work you've done. I'm beyond impressed by the team you've assembled and the depth of research that you did. I've worked with other consultants before in various projects, and they 'll shortcut a lot of the diligence that needs to be done to truly understand the market. You've exceeded my expectations on the depth of research. I've been impressed with the process.” Tony Recupero President, Commercial Operations at SI-BONE * “In my short time at ReGelTec, Cris Venner at bioaccess® has been fantastic to work with. She is doing a great job, and no matter how often I send her a message on WhatsApp (which is a lot) with a request, she always responds quickly and gets me what I need (with a positive attitude). For example, I sent Cris a message a little after 8 AM for an urgent request (needing something for a 10 AM meeting), and she quickly got me everything I needed. Cris and the rest of the team at bioaccess® make this process easy for me because managing an OUS clinical study isn't easy. I just wanted to make sure you knew how much I value Cris and her great job.” Robert Townsend Senior Director Clinical Affairs ReGelTec, Inc. * “Obtaining approval for a foreign study is always a challenge. bioaccess's assistance was invaluable in getting our study approved in Colombia. In addition to having an in-depth knowledge of the regulatory approval process, they also have a deep understanding of the culture. As a result, bioaccess™ can identify and troubleshoot potential problems before they arise. For companies considering a trial in Colombia, I recommend bioaccess™ without hesitation.” Robert Berman CEO at enVVeno Medical Corporation Item 1 of 3 COMMITTED TO YOUR SUCCESS bioaccess® is a US-based CRO that bridges the gap between innovative Medtech companies and the untapped potential of conducting clinical research studies in Latin America. Our team believes in the importance of your medical device and the benefit it could bring to people’s lives. We are committed to helping you navigate the convoluted and uncertain developmental challenges of being an early-stage startup. Our priority is bringing you fast, cost-effective, and high-quality clinical data. LEARN MORE bioaccess® is a proud member of the U.S. Commercial Service's Business Service Provider Directory to help U.S. Medtech companies do business and succeed in Colombia. bioaccess® is a proud member of the American-Colombian Chamber of Commerce (AMCHAM), an organization that since 1955 has been the main interlocutor of the US and Colombian governments for trade and investment in both countries. bioaccess® is a proud member of the Council of American enterprises (CEA) in Colombia. CEA strengthens the community of U.S. companies established in Colombia, working through high-level strategic connections in order to make visible the common interests and visions of its affiliates. IMH ASSETS CORP (dba bioaccess®) 1200 Brickell Avenue, Suite 1950 #1034, Miami, FL 33131 166 Geary Street, 15th Floor #1181, San Francisco, CA 94108 -------------------------------------------------------------------------------- Testimonials Services Home Podcast FAQ About Solutions News Blog Contact CONTACT US: BOOK A MEETING | E-MAIL | CALL US: +1 (305) 539-9106 -------------------------------------------------------------------------------- Copyright © 2024 IMH ASSETS CORP. All rights reserved. bioaccess® is a registered trademark of IMH ASSETS CORP. BOOK A MEETING × NOTICE We and selected third parties use cookies or similar technologies for technical purposes and, with your consent, for functionality, experience, measurement and “marketing (personalized ads)”. With respect to advertising, we and 906 selected third parties, may use precise geolocation data, and identification through device scanning in order to store and/or access information on a device and process personal data like your usage data for the following advertising purposes: personalised advertising and content, advertising and content measurement, audience research and services development. You can freely give, deny, or withdraw your consent at any time by accessing the preferences panel. If you give consent, it will be valid only in this domain. Denying consent may make related features unavailable. Use the “Accept” button to consent. Use the “Reject” button or close this notice to continue without accepting. Press again to continue 0/1 Learn more and customize RejectAccept